LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)
US5393192027 - Common Stock
0.6625 -0.03 (-4.37%)
After market: 0.7 +0.04 (+5.66%)
|Non Recurring Items||N/A||N/A||N/A||N/A||N/A|
|Income Before Taxes||-6.02M||-6.31M||-6.73M||-3.26M||-2.44M|
| Per Share Data|
|EPS Diluted Total Ops||-0.36||-0.40||-0.50||-0.29||-0.22|
Compare to the relevant previous number. (Y2Y or Q2Q)
'Revenue' or 'Sales' is the total gross income generated from business operations.
'Non Recurring Items'.
'Operating Expenses' are the remaining expenses, not included in 'Cost Of Goods'
'Interest Expense' is the net amount spent on interests from borrowings.
'Income Before Taxes' is the total of Revenue minus expenses, before Tax.
'Income Tax' is the total Tax paid.
'Net Income' is the total profit or loss of the company.
'Earnings Per Share' or the Net Income Per Share outstanding, including all convertible securities for Total Operations
The 'Profit Margin' is the Net Profit compared to revenue as a percentage